Abstract:The clinical efficacy of tyrosine kinase inhibitors supports the dependence of distinct subsets of cancers on specific driver mutations for survival, a phenomenon called "oncogene addiction." We demonstrate that PUMA and BIM are the key apoptotic effectors of tyrosine kinase inhibitors in breast cancers with amplification of the gene encoding human epidermal growth factor receptor 2 (HER2) and lung cancers with epidermal growth factor receptor (EGFR) mutants. The BH3 domain containing proteins BIM and PUMA can directly activate the proapoptotic proteins BAX and BAK to permeabilize mitochondria, leading to caspase activation and apoptosis. We delineated the signal transduction pathways leading to the induction of BIM and PUMA by tyrosine kinase inhibitors. Inhibition of the mitogen-activated or extracellular signal-regulated protein kinase kinase (MEK)-extracellular signal-regulated kinase (ERK) pathway caused increased abundance of BIM, whereas antagonizing the phosphoinositide 3-kinase (PI3K)-AKT pathway triggered nuclear translocation of the FOXO transcription factors, which directly activated the PUMA promoter. In a mouse breast tumor model, the abundance of PUMA and BIM was increased after inactivation of HER2. Moreover, deficiency of Bim or Puma impaired caspase activation and reduced tumor regression caused by inactivation of HER2. Similarly, deficiency of Puma impeded the regression of EGFR(L858R)-driven mouse lung tumors upon inactivation of the EGFR-activating mutant. Overall, our study identified PUMA and BIM as the sentinels that interconnect kinase signaling networks and the mitochondrion-dependent apoptotic program, which offers therapeutic insights for designing novel cell death mechanism-based anticancer strategies.

Apoptosis Induced by PGC-1β in Breast Cancer Cells is Mediated by the Mtor Pathway.

PGC-1α Induces Apoptosis in Human Epithelial Ovarian Cancer Cells Through a PPARγ-dependent Pathway

Post-translational regulation of PGC-1α modulates fibrotic repair.

Anti-proliferation and Apoptosis Induced Via the Mtor/pgc-1Α Signaling Pathway in Trophoblast Cells of Miscarriage.

Integrative analysis of differentially expressed mRNAs and proteins induced by PGC-1β in breast cancer cells

20(S)-Protopanaxadiol-induced Apoptosis in MCF-7 Breast Cancer Cell Line Through the Inhibition of PI3K/AKT/mTOR Signaling Pathway

Glucocorticoid Receptor Activation Inhibits P53-Induced Apoptosis of MCF10Amyc Cells Via Induction of Protein Kinase Cϵ

Targeted Inhibition of Mtor by BML-275 Induces Mitochondrial-Mediated Apoptosis and Autophagy in Prostate Cancer.

The Role of PGC 1 a in Cancer Metabolism and its Therapeutic Implications

PPARγ Activation Induces Autophagy in Breast Cancer Cells

PUMA and BIM Are Required for Oncogene Inactivation–Induced Apoptosis

Posttranslational Regulation of PGC-1 Alpha and Its Implication in Cancer Metabolism

p53/PGC‑1α‑mediated mitochondrial dysfunction promotes PC3 prostate cancer cell apoptosis.

The Role of PGC1α in Cancer Metabolism and its Therapeutic Implications.

p53/PGC-1-mediated mitochondrial dysfunction promotes PC3 prostate cancer cell apoptosis

Activation of Peroxisome Proliferator-Activated Receptor Gamma Induces the Apoptosis in Human Colon Cancer Cells

Mtor Signaling Pathway and Apoptosis

PGC1β Regulates Breast Tumor Growth and Metastasis by SREBP1-Mediated HKDC1 Expression

PGC-1α Prevents Apoptosis in Adipose-Derived Stem Cells by Reducing Reactive Oxygen Species Production in a Diabetic Microenvironment.

[Peroxisome Proliferator Activated Receptor Gamma Coactivator-1 Induces Apoptosis in Human Epithelial Ovarian Cancer Cells].

Pgc-1 Beta-Regulated Mitochondrial Biogenesis and Function in Myotubes is Mediated by Nrf-1 and Err Alpha